Qiagen NV
QGEN48.560USD
+1.340+2.84%
收盤 11/25, 16:00（美東）報價延遲15分鐘
10.53B總市值
25.98本益比TTM
關於 Qiagen NV 公司
Qiagen NV 是一家總部位於荷蘭的控股公司。該公司致力於提供從樣本到洞察的解決方案，將生物樣本轉化爲分子洞察。其從樣本到洞察解決方案集成了樣本和分析技術、生物信息學和自動化系統。其樣本技術用於從血液或其他液體、組織、植物或其他材料中分離和製備脫氧核糖核酸 (DNA)、核糖核酸 (RNA) 和蛋白質。其分析技術使這些生物分子可見以供分析，例如識別病原體的遺傳信息或腫瘤中的基因突變。其生物信息學解決方案解釋數據以提供可操作的洞察。該公司基於聚合酶鏈反應 (PCR)、下一代測序 (NGS) 和其他技術的自動化平臺將這些技術結合在一起，形成從樣本到洞察的分子檢測工作流程。
Qiagen NV簡介
公司代碼QGEN
公司名稱Qiagen NV
上市日期Sep 01, 1996
CEOMr. Thierry Bernard
員工數量5765
證券類型Ordinary Share
年結日Sep 01
公司地址Hulsterweg 82
城市VENLO
上市交易所NYSE Consolidated
國家Netherlands
郵編5912 PL
電話31773556600
網址https://www.qiagen.com/
公司代碼QGEN
上市日期Sep 01, 1996
CEOMr. Thierry Bernard
Qiagen NV公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
383.09K
+59.93%
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
312.13K
+75.76%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
171.79K
-57.00%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
47.22K
+10.37%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
16.27K
+30.83%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.97K
--
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
24.00
--
Ms. Eva van Pelt
Ms. Eva van Pelt
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Toralf Haag, Ph.D.
Dr. Toralf Haag, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert van Meurs
Mr. Bert van Meurs
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
383.09K
+59.93%
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
312.13K
+75.76%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
171.79K
-57.00%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
47.22K
+10.37%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
16.27K
+30.83%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.97K
--
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
業務USD
名稱
營收
佔比
Consumables and Related Revenues
476.33M
89.28%
Instrumentation
57.21M
10.72%
地區USD
名稱
營收
佔比
United States
260.49M
48.82%
Europe & Middle East & Africa
179.30M
33.61%
Asia, Pacific & Rest of the World
73.46M
13.77%
Other Americas
20.29M
3.80%
業務
地區
業務USD
名稱
營收
佔比
Consumables and Related Revenues
476.33M
89.28%
Instrumentation
57.21M
10.72%
股東統計
更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
Wellington Management Company, LLP
10.76%
MFS Investment Management
10.56%
The Vanguard Group, Inc.
4.30%
T. Rowe Price International Ltd
3.47%
DWS Investment GmbH
2.13%
其他
68.78%
持股股東
持股股東
佔比
Wellington Management Company, LLP
10.76%
MFS Investment Management
10.56%
The Vanguard Group, Inc.
4.30%
T. Rowe Price International Ltd
3.47%
DWS Investment GmbH
2.13%
其他
68.78%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
48.71%
Investment Advisor
25.43%
Research Firm
5.08%
Pension Fund
1.63%
Sovereign Wealth Fund
1.60%
Hedge Fund
1.10%
Bank and Trust
1.09%
Individual Investor
0.44%
Insurance Company
0.05%
其他
14.86%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
996
177.81M
82.00%
-32.33M
2025Q2
996
189.55M
87.53%
+6.64M
2025Q1
1017
179.03M
82.67%
+27.58M
2024Q4
1010
129.03M
59.70%
-70.06M
2024Q3
1010
183.22M
84.72%
-23.62M
2024Q2
1002
184.34M
84.75%
+8.40M
2024Q1
988
165.20M
76.61%
-7.18M
2023Q4
993
165.11M
76.72%
-10.52M
2023Q3
987
159.93M
74.32%
-12.21M
2023Q2
996
162.43M
75.49%
-6.05M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Wellington Management Company, LLP
26.02M
12%
+1.59M
+6.49%
Jun 30, 2025
MFS Investment Management
23.48M
10.83%
-787.04K
-3.24%
Jun 30, 2025
The Vanguard Group, Inc.
9.16M
4.22%
+372.54K
+4.24%
Jun 30, 2025
T. Rowe Price International Ltd
5.94M
2.74%
+1.79M
+43.10%
Jun 30, 2025
DWS Investment GmbH
3.30M
1.52%
+2.74M
+482.72%
Jun 30, 2025
EARNEST Partners, LLC
4.20M
1.94%
+395.58K
+10.39%
Jun 30, 2025
Amundi Asset Management, SAS
3.98M
1.83%
-217.72K
-5.19%
Jun 30, 2025
Boston Partners
2.36M
1.09%
+13.48K
+0.58%
Aug 31, 2025
BlackRock Institutional Trust Company, N.A.
20.54M
9.47%
+174.28K
+0.86%
Sep 10, 2025
查看更多
持股ETF
更新時間: 11月6日 週四
更新時間: 11月6日 週四
機構名稱
佔比
First Trust Nasdaq Lux Digi Health Solutions ETF
3.85%
Global X Genomics & Biotechnology ETF
3.76%
Invesco Biotechnology & Genome ETF
2.45%
VanEck Biotech ETF
1.81%
ROBO Global Healthcare Technology & Innovation ETF
1.46%
Pacer US Large Cap Cash Cows Growth Leaders ETF
1.18%
Franklin Genomic Advancements ETF
1%
iShares Health Innovation Active ETF
0.93%
Burney US Factor Rotation ETF
0.75%
WisdomTree International Multifactor Fund
0.68%
查看更多
First Trust Nasdaq Lux Digi Health Solutions ETF
佔比3.85%
Global X Genomics & Biotechnology ETF
佔比3.76%
Invesco Biotechnology & Genome ETF
佔比2.45%
VanEck Biotech ETF
佔比1.81%
ROBO Global Healthcare Technology & Innovation ETF
佔比1.46%
Pacer US Large Cap Cash Cows Growth Leaders ETF
佔比1.18%
Franklin Genomic Advancements ETF
佔比1%
iShares Health Innovation Active ETF
佔比0.93%
Burney US Factor Rotation ETF
佔比0.75%
WisdomTree International Multifactor Fund
佔比0.68%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 18, 2024
Merger
25→24.25
Jan 18, 2024
Merger
25→24.25
公告日期
類型
比率
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 18, 2024
Merger
25→24.25
Jan 18, 2024
Merger
25→24.25
Jan 18, 2024
Merger
25→24.25
Jan 18, 2024
Merger
25→24.25
常見問題
Qiagen NV的前五大股東是誰？
Qiagen NV的前五大股東如下：
Wellington Management Company, LLP持有股份：26.02M佔總股份比例：12.00%。
MFS Investment Management持有股份：23.48M佔總股份比例：10.83%。
The Vanguard Group, Inc.持有股份：9.16M佔總股份比例：4.22%。
T. Rowe Price International Ltd持有股份：5.94M佔總股份比例：2.74%。
DWS Investment GmbH持有股份：3.30M佔總股份比例：1.52%。
Wellington Management Company, LLP持有股份：26.02M佔總股份比例：12.00%。
MFS Investment Management持有股份：23.48M佔總股份比例：10.83%。
The Vanguard Group, Inc.持有股份：9.16M佔總股份比例：4.22%。
T. Rowe Price International Ltd持有股份：5.94M佔總股份比例：2.74%。
DWS Investment GmbH持有股份：3.30M佔總股份比例：1.52%。
Qiagen NV的前三大股東類型是什麼？
Qiagen NV 的前三大股東類型分別是：
Wellington Management Company, LLP
MFS Investment Management
The Vanguard Group, Inc.
Wellington Management Company, LLP
MFS Investment Management
The Vanguard Group, Inc.
有多少機構持有Qiagen NV(QGEN)的股份？
截至2025Q3，共有996家機構持有Qiagen NV的股份，合計持有的股份價值約為177.81M，占公司總股份的82.00% 。與2025Q2相比，機構持股有所增加，增幅為-5.53%。
哪個業務部門對Qiagen NV的收入貢獻最大？
在FY2025Q2，Consumables and Related Revenues業務部門對Qiagen NV的收入貢獻最大，創收476.33M，占總收入的89.28% 。
